Logotype for The Navigator Company S.A

The Navigator Company (NVG) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Navigator Company S.A

Q2 2026 earnings summary

1 Aug, 2026

Executive summary

  • H1 2026 performance was impacted by adverse weather, operational constraints, and geopolitical uncertainty, but underlying business performance improved with strong pricing recovery, efficiency gains, and cost optimization across all segments.

  • Strategic investments in efficiency, sustainability, and diversification advanced, including major projects in tissue and packaging, supporting long-term competitiveness and growth.

  • Net debt reduced by €10 million, with Net Debt/EBITDA at 2.29x and a strong financial position maintained.

  • Diversification into Tissue and Packaging segments strengthened resilience, with Tissue now 25% and Packaging 6% of turnover.

Financial highlights

  • H1 2026 turnover was €869 million, down 15% year-over-year; EBITDA reached €143 million, down 34% year-over-year but up 21% quarter-over-quarter.

  • CapEx in H1 2026 totaled €127 million, with 57% allocated to sustainability and ESG projects.

  • Free cash flow for H1 2026 was €10 million, down from €42 million in H1 2025, impacted by high CapEx and operational constraints.

  • Liquidity stood at €590 million, with €179 million in cash and €413 million in unused credit facilities.

  • Net debt at June 30, 2026 was €693 million, with a net debt ratio of 2.29x and average cost of finance at 2.9%.

Outlook and guidance

  • CapEx in H2 2026 and 2027 expected below H1 2026 levels, supporting stronger cash generation.

  • Pulp prices in Europe expected to strengthen and stabilize, with limited new capacity and delayed projects; average 2026 prices should exceed 2025.

  • Paper and tissue prices anticipated to rise in Q3, with ongoing capacity rationalization and strategic consolidation supporting market balance.

  • EBITDA margins targeted to improve in H2, aiming for 23.5%-24% (excluding U.K. operations), though dependent on pulp price trends.

  • Packaging and Tissue segments expected to see continued demand and price increases, with efficiency programs offsetting cost inflation.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more